Showing results (191-200 of 208) with videos related to

Sort By:
Pageof 21
American Journal of Obstetrics and Gynecology|August 7, 2022
Early natural menopause is associated with poor lung health and increased mortality among female smokersTing Zhai, Brenda Diergaarde, David O Wilson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 22, 2012
Tumor epidermal growth factor receptor and EGFR PY1068 are independent prognostic indicators for head and neck squamous cell carcinomaSarah Wheeler, Doris R Siwak, Raymond Chai, et al.
American Journal of Respiratory Cell and Molecular Biology|December 19, 2018
Lung Adenocarcinoma Syndecan-2 Potentiates Cell InvasivenessKonstantin Tsoyi, Juan C Osorio, Sarah G Chu, et al.
Oncotarget|October 4, 2017
Gene methylation biomarkers in sputum as a classifier for lung cancer riskShuguang Leng, Guodong Wu, Donna M Klinge, et al.
Clinical Proteomics|August 13, 2014
Validation of a blood protein signature for non-small cell lung cancerMichael R Mehan, Stephen A Williams, Jill M Siegfried, et al.
Plos One|December 21, 2010
Unlocking biomarker discovery: large scale application of aptamer proteomic technology for early detection of lung cancerRachel M Ostroff, William L Bigbee, Wilbur Franklin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 28, 2009
HGF and c-Met participate in paracrine tumorigenic pathways in head and neck squamous cell cancerLynn M Knowles, Laura P Stabile, Ann Marie Egloff, et al.
American Journal of Respiratory and Critical Care Medicine|August 31, 2017
Lung Endothelial MicroRNA-1 Regulates Tumor Growth and AngiogenesisAsawari Korde, Lei Jin, Jian-Ge Zhang, et al.
Cancer Biomarkers : Section a of Disease Markers|December 29, 2006
Multianalyte profiling of serum cytokines for detection of pancreatic cancerH J Zeh, S Winikoff, D P Landsittel, et al.
Cancer|May 5, 2017
Phase 1/2 study of rilotumumab (AMG 102), a hepatocyte growth factor inhibitor, and erlotinib in patients with advanced non-small cell lung cancerAhmad A Tarhini, Imran Rafique, Theofanis Floros, et al.
Pageof 21